Comment on: Safety and efficacy of mirabegron: analysis of a large integrated clinical trial database of patients with overactive bladder receiving mirabegron, antimuscarinics, or placebo

Carmen Scandura, Giuseppe Morgia, Giorgio Ivan Russo